Oppenheimer & CO Inc Prime Medicine, Inc. Transaction History
Oppenheimer & CO Inc
- $6.52 Billion
- Q4 2024
A detailed history of Oppenheimer & CO Inc transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 12,106 shares of PRME stock, worth $35,954. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,106
Previous 17,871
32.26%
Holding current value
$35,954
Previous $69,000
49.28%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding PRME
# of Institutions
136Shares Held
60.9MCall Options Held
42.6KPut Options Held
173K-
Alphabet Inc. Mountain View, CA15.1MShares$44.7 Million3.11% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.15MShares$15.3 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.11MShares$15.2 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.98MShares$11.8 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.66MShares$10.9 Million0.0% of portfolio
About Prime Medicine, Inc.
- Ticker PRME
- Shares Outstandng 95,730,200
- Market Cap $284M